Multiple nuclear medicine and cardiology groups are working to oppose potential cuts to myocardial PET scans that were made possible by the CMS 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, according to a joint statement.

When CMS released the 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, it included revisions that could lead to technical component payment reductions of up to 80% for certain services related to myocardial PET scans.

Using contrast-enhanced digital mammography (CEDM) to evaluate low to moderately suspicious breast lesions can greatly reduce biopsies in patients with benign lesions, according to a study published Sept. 5 in Academic Radiology.

Patients with a family or personal history of allergic reactions to contrast media are in danger of experiencing future reactions, according to a study published Sept. 3 in Radiology.  

Many radiologists believe patient-provider discussions about screening mammography and supplemental screening are inadequate, according to findings published in the Journal of Breast Imaging. The specialty appears ready to step up and take a more visible role in patient education.

Using [68Ga]Ga-PSMA-11 PET/CT to monitor treatment response in prostate cancer patients can offer important lesion-based insights over prostate-specific membrane antigen (PSMA)-based monitoring, according to a new study published in EJNMMI Research.

Providing patients more testing choices does not increase their participation in colorectal cancer screening—but the way clinician’s framed those choices did, according to a new study published in JAMA Network Open.

The Department of Energy (DOE)’s National Nuclear Security Administration has issued a fourth, and final, cooperative agreement to Corvallis, Oregon-based Northwest Medical Isotopes, LLC.